Previous Article | Next Article ![]()
Journal of Clinical Microbiology, December 1999, p. 3809-3814, Vol. 37, No. 12
Department of Clinical
Laboratory1 and Trauma and Critical Care
Center,
Received 13 January 1999/Returned for modification 27 February
1999/Accepted 21 August 1999
We experienced two Burkholderia cepacia outbreaks over
a 1-year period. During this period, 28 B. cepacia isolates
were obtained from clinical specimens, and 2 were obtained from
environmental specimens (i.e., from a nebulizer solution and a
nebulizer tube). These 30 isolates were subjected to the PCR-based
randomly amplified polymorphic DNA (RAPD) assay as well as to
pulsed-field gel electrophoresis (PFGE). In the first outbreak, in
which eight patients hospitalized in the Trauma and Critical Care
Center were involved, the RAPD assay revealed that all 20 isolates
obtained from clinical specimens and the 2 isolates from environmental
specimens had identical DNA profiles. These RAPD data enabled us to
pinpoint a possible source and to take countermeasures to prevent
further spread of the epidemic-causing strain. In the second outbreak,
two consecutive B. cepacia infection/colonization cases
were seen in the surgery ward. The RAPD profiles of four isolates
obtained were again identical, but they were distinct from those seen
in the first outbreak, clearly indicating that the second outbreak was
not related to the first. Thus, our experience demonstrated that the
RAPD assay is a useful and reliable tool for epidemiological studies of
B. cepacia isolates from nosocomial outbreaks. Since the
RAPD assay could provide discriminatory potential and reproducibility
comparable to those of the widely used PFGE assay with less complexity
and in a shorter time, the introduction of the RAPD assay into hospital microbiology laboratories as a routine technique may help prevent nosocomial outbreaks.
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Molecular Epidemiological Investigation Using a
Randomly Amplified Polymorphic DNA Assay of Burkholderia
cepacia Isolates from Nosocomial Outbreaks
*
Corresponding author. Mailing address: Department of
Clinical Laboratory, Kyorin University Hospital, 6-20-2 Shinkawa,
Mitaka, Tokyo 181-8611, Japan. Phone: (81) 422 47 5511, ext. 2805. Fax: (81) 422 79 3471. E-mail:
ur9t-wtnb{at}asahi-net.or.jp.
Journal of Clinical Microbiology, December 1999, p. 3809-3814, Vol. 37, No. 12
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»